Neoplasms, Endometrial Withdrawn Phase 2 Trials for Doxorubicin (DB00997)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03005015Lenvatinib in Second Line Endometrial CarcinomaTreatment